Filing Details
- Accession Number:
- 0001209191-14-011279
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-02-18 16:10:39
- Reporting Period:
- 2014-02-14
- Filing Date:
- 2014-02-18
- Accepted Time:
- 2014-02-18 16:10:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 31791 | Perkinelmer Inc | PKI | Laboratory Analytical Instruments (3826) | 042052042 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1197020 | L Vicki Sato | 940 Winter Street Waltham MA 02451 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-02-14 | 5,854 | $19.91 | 51,224 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-02-14 | 7,097 | $24.27 | 58,321 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-02-14 | 8,892 | $26.49 | 67,213 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-02-14 | 21,843 | $43.97 | 45,370 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | NQ Stock Option (right to buy) | Disposition | 2014-02-14 | 5,854 | $0.00 | 5,854 | $19.91 |
| Common Stock | NQ Stock Option (right to buy) | Disposition | 2014-02-14 | 7,097 | $0.00 | 7,097 | $24.27 |
| Common Stock | NQ Stock Option (right to buy) | Disposition | 2014-02-14 | 8,892 | $0.00 | 8,892 | $26.49 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2014-04-27 | No | 4 | M | Direct | |
| 0 | 2014-05-01 | No | 4 | M | Direct | |
| 0 | 2015-04-29 | No | 4 | M | Direct |
Footnotes
- The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $43.940 to $44.010. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
- This option became exercisable in three equal annual installments beginning on April 27, 2005, which was the first anniversary of the date on which the option was granted, and had a 10 year exercise term.
- This option became exercisable in three equal annual installments beginning on May 1, 2008, which was the first anniversary of the date on which the option was granted, and had a 7 year exercise term.
- This option became exercisable in three equal annual installments beginning on April 29, 2009, which was the first anniversary of the date on which the option was granted, and had a 7 year exercise term.
Billionaire Hedge Funds
